January 16, 2014 / 4:56 PM / 4 years ago

BRIEF-Thrombogenics says Jetrea become eligible for reimbursement in France

1 Min Read

BRUSSELS, Jan 16 (Reuters) - ThromboGenics NV : * France's transparency commission issues positive opinion for reimbursement of Jetrea * CT recommends Jetrea for the treatment of adult patients with vitreomacular traction * Says drug Jetrea becomes eligible for reimbursement in France

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below